Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.

Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE.

Hepatology. 2010 May;51(5):1531-7. doi: 10.1002/hep.23464. Erratum in: Hepatology. 2015 Oct;62(4):1330.

2.

No inflammation? No cancer! Clear HBV early and live happily.

Villa E, Fattovich G.

J Hepatol. 2010 May;52(5):768-70. doi: 10.1016/j.jhep.2010.01.018.

4.

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

McMahon BJ, Holck P, Bulkow L, Snowball M.

Ann Intern Med. 2001 Nov 6;135(9):759-68.

PMID:
11694101
5.

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007.

PMID:
22333950
6.
7.

Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.

Kim GA, Lee HC, Kim MJ, Ha Y, Park EJ, An J, Lee D, Shim JH, Kim KM, Lim YS.

J Hepatol. 2015 May;62(5):1092-9. doi: 10.1016/j.jhep.2014.11.031.

PMID:
25445399
8.

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ, Su TH, Batrla-Utermann R, Chan HL, Kao JH, Chen CJ.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):461-468.e2. doi: 10.1016/j.cgh.2015.10.033.

PMID:
26598229
9.

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.

Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.

J Med Virol. 2009 Sep;81(9):1531-8. doi: 10.1002/jmv.21577.

PMID:
19623669
10.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.

PMID:
15850475
11.

Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.

Habersetzer F, Moenne-Loccoz R, Meyer N, Schvoerer E, Simo-Noumbissie P, Dritsas S, Baumert TF, Doffoël M.

Liver Int. 2015 Jan;35(1):130-9. doi: 10.1111/liv.12661.

PMID:
25145784
12.

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group..

N Engl J Med. 2002 Jul 18;347(3):168-74.

13.

Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study.

Lim TH, Gane E, Moyes C, Borman B, Cunningham C.

Gut. 2015 Jun;64(6):966-72. doi: 10.1136/gutjnl-2013-306247.

PMID:
25006011
14.

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL.

Hepatology. 2004 Jun;39(6):1694-701. Erratum in: Hepatology. 2004 Sep;40(3):767.

PMID:
15185311
15.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943.

16.

Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.

Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G.

Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032.

PMID:
25281206
17.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146.

18.

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.

Cancer. 1999 May 15;85(10):2132-7.

PMID:
10326690
19.

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A.

Cancer. 1994 Nov 1;74(9):2442-8.

20.

[Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].

Sun Y, Chen TY, Lu PX, Wang JB, Wu Y, Zhang QN, Qian GS, Tu H.

Zhonghua Yi Xue Za Zhi. 2012 Jul 17;92(27):1874-7. Chinese.

PMID:
23134955
Items per page

Supplemental Content

Support Center